Mitochondrial dysfUnction: a Key Player in Doxorubicin-induced Skeletal and Cardiac muscLE Damage

Not yet recruitingOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

April 30, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions

Doxorubicin Induced CardiomyopathyChemotherapeutic ToxicityB-cell LymphomaT-cell Lymphoma

Interventions

DIAGNOSTIC_TEST

31-MRS at 7 Tesla (T)

31-MRS imaging at 7T to evaluate mitochondrial function in skeletal and cardiac muscles.

Trial Locations (2)

Diakonessenhuis, Utrecht

UMC Utrecht, Utrecht